The total synthesis of a natural cardenolide: (+)-digitoxigenin

Journal of the American Chemical Society

Volumn 118, Issue 43, 1996, Pages 10660-10661

  Stork, Gilbert ^a   West, Fred ^a,b   Lee, Hee Yoon ^a,c   Isaacs, Richard C A ^a,d   Manabe, Shino ^a,e  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^d MERCK RESEARCH LABORATORIES   (United States)

^e TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARDENOLIDE; DIGITOXIGENIN;

ARTICLE; CHIRALITY; DRUG SYNTHESIS; ENANTIOMER; NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS;

EID: 0029844604     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja962163m     Document Type: Article

References (51)

1. Inter alia: (a) Aronson, J. K. An Account of the Foxglove and its Medicinal Uses 1785-1985; Oxford University Press: London, 1985. (b) Cardiac Glycosides; Erdmann, E., Greff, K., Skou, J. C., Eds.; International Boehringer Mannheim Symposia; Springer Verlag: New York, 1986. (c) Digitalis Glycosides; Smith, Th., Ed.; Grime & Stratton, Inc.: Orlando, FL, 1986. (d) Gunthert, Th. W.; Linde, H. H. A. Experientia 1977, 33, 697.
2. Inter alia: (a) Aronson, J. K. An Account of the Foxglove and its Medicinal Uses 1785-1985; Oxford University Press: London, 1985. (b) Cardiac Glycosides; Erdmann, E., Greff, K., Skou, J. C., Eds.; International Boehringer Mannheim Symposia; Springer Verlag: New York, 1986. (c) Digitalis Glycosides; Smith, Th., Ed.; Grime & Stratton, Inc.: Orlando, FL, 1986. (d) Gunthert, Th. W.; Linde, H. H. A. Experientia 1977, 33, 697.
3. Inter alia: (a) Aronson, J. K. An Account of the Foxglove and its Medicinal Uses 1785-1985; Oxford University Press: London, 1985. (b) Cardiac Glycosides; Erdmann, E., Greff, K., Skou, J. C., Eds.; International Boehringer Mannheim Symposia; Springer Verlag: New York, 1986. (c) Digitalis Glycosides; Smith, Th., Ed.; Grime & Stratton, Inc.: Orlando, FL, 1986. (d) Gunthert, Th. W.; Linde, H. H. A. Experientia 1977, 33, 697.
4. Inter alia: (a) Aronson, J. K. An Account of the Foxglove and its Medicinal Uses 1785-1985; Oxford University Press: London, 1985. (b) Cardiac Glycosides; Erdmann, E., Greff, K., Skou, J. C., Eds.; International Boehringer Mannheim Symposia; Springer Verlag: New York, 1986. (c) Digitalis Glycosides; Smith, Th., Ed.; Grime & Stratton, Inc.: Orlando, FL, 1986. (d) Gunthert, Th. W.; Linde, H. H. A. Experientia 1977, 33, 697.
5. See: Fieser, L. F.; Fieser, M. Steroids; Reinhold Publishing Corp.: New York, 1959; Chapter 20.
6. (a) Danieli, N.; Mazur, Y.; Sondheimer, F. J. Am. Chem. Soc. 1962, 84, 875.
7. (b) For a review of early work, see: Sondheimer, F. Chem. Br. 1965, 1, 454,
8. (c) Bach, G.; Capitaine, J.; Engel, C. R. Can. J. Chem. 1968, 46, 733 and references therein,
9. (d) Fritsch, W.; Haede, W.; Radscheit, K.; Stache, U.; Ruschig, H. Liebigs Ann. Chem. 1974, 621.
10. (e) Yoshii, E.; Koizumi, T.; Ikeshima, H.; Uzaki, K.; Hayashi, I. Chem. Pharm. Bull. 1975, 23, 2496.
11. (f) Donovan, S. F.; Avery, M. A.; McMurry, J. E. Tetrahedron Lett. 1979, 3287.
12. (g) Marini-Bettolo, R.; Flecker, P.; Tsai, T. Y. R.; Wiesner, K. Can. J. Chem. 1981, 59, 1403.
13. (h) Kocovsky, P.; Cerny, V. Coll. Czech. Commun. 1981, 46, 446.
14. (i) Welzel, P.; Stein, H.; Milkova, T. Liebigs Ann. Chem. 1982, 2119.
15. (j) Wicha, J.; Kabat, M. M. J. Chem. Soc., Chem. Commun. 1983, 985.
16. (k) Wicha, J.; Kabat, M. M. J. Chem. Soc., Perkin Trans, 1 1985. 50, 1990.
17. (l) Wiesner, K.; Tsai, T. Y. R. Pure Appl. Chem. 1986, 58, 799.
18. (m) Kutney, J. P.; Piotrowska, K.; Somerville, J.; Huang, S. P.; Rettig, S. J. Can. J. Chem. 1989, 67, 580.
19. (n) Groszek, G.; Kurek-Tyrlik, A.; Wicha, J. Tetrahedron 1989, 45, 2223.
20. (o) Kocovsky, P.; Stieborova, I. Tetrahedron Lett. 1989, 30, 4295.
21. For some total synthesis contributions, see: (a) Stryker, J. M. Diss. Abstr. Int. B 1984, 24, 2432. (b) Daniewski, A. R.; Kabat, M. M.; Masnyk, M.; Wicha, J.; Wojciechowska, W. J. Org. Chem. 1988, 53, 4855 (for an interesting total synthesis of the 9,11-dehydro relative of a digitoxigenin derivative), (c) Ruel, R.; Deslongchamps, P. Tetrahedron Lett. 1990, 31, 3961 (d) Laschat, S.; Narjes, F.; Overman, L. E. Tetrahedron 1994, 50, 347.
22. For some total synthesis contributions, see: (a) Stryker, J. M. Diss. Abstr. Int. B 1984, 24, 2432. (b) Daniewski, A. R.; Kabat, M. M.; Masnyk, M.; Wicha, J.; Wojciechowska, W. J. Org. Chem. 1988, 53, 4855 (for an interesting total synthesis of the 9,11-dehydro relative of a digitoxigenin derivative), (c) Ruel, R.; Deslongchamps, P. Tetrahedron Lett. 1990, 31, 3961 (d) Laschat, S.; Narjes, F.; Overman, L. E. Tetrahedron 1994, 50, 347.
23. For some total synthesis contributions, see: (a) Stryker, J. M. Diss. Abstr. Int. B 1984, 24, 2432. (b) Daniewski, A. R.; Kabat, M. M.; Masnyk, M.; Wicha, J.; Wojciechowska, W. J. Org. Chem. 1988, 53, 4855 (for an interesting total synthesis of the 9,11-dehydro relative of a digitoxigenin derivative), (c) Ruel, R.; Deslongchamps, P. Tetrahedron Lett. 1990, 31, 3961 (d) Laschat, S.; Narjes, F.; Overman, L. E. Tetrahedron 1994, 50, 347.
24. For some total synthesis contributions, see: (a) Stryker, J. M. Diss. Abstr. Int. B 1984, 24, 2432. (b) Daniewski, A. R.; Kabat, M. M.; Masnyk, M.; Wicha, J.; Wojciechowska, W. J. Org. Chem. 1988, 53, 4855 (for an interesting total synthesis of the 9,11-dehydro relative of a digitoxigenin derivative), (c) Ruel, R.; Deslongchamps, P. Tetrahedron Lett. 1990, 31, 3961 (d) Laschat, S.; Narjes, F.; Overman, L. E. Tetrahedron 1994, 50, 347.
25. Buchschacher, P.; Furst, A.; Gutzwiller, J. Organic Syntheses; Wiley: New York, 1990; Collect. Vol. VII, 368. Gutzwiller, J.; Buchschacher, P.; Furst, A. Synthesis 1977, 167.
26. Buchschacher, P.; Furst, A.; Gutzwiller, J. Organic Syntheses; Wiley: New York, 1990; Collect. Vol. VII, 368. Gutzwiller, J.; Buchschacher, P.; Furst, A. Synthesis 1977, 167.
27. (a) Corey, E. J.; Ohno, M.; Mitra, R. B.; Vatakencherry, P. A. J. Am. Chem. Soc. 1964, 86, 478.
28. (b) McMurry, J. J. Am. Chem. Soc. 1968, 90, 6821.
29. (c) Camps, P.; Ortuno, R. M.; Serratosa, F. Tetrahedron Lett. 1978, 3159.
30. (a) Clark, R. D.; Heathcock, C. H. Tetrahedron Lett. 1974, 2027.
31. (b) Zhou, W. S.; Jiang, B.; Pan, X. F. J. Chem. Soc., Chem. Commun. 1988, 791.
32. Ikeda, Y.; Ukai, J.; Ikeda, N.; Yamamoto, H. Tetrahedron 1987, 43, 723.
33. Lythgoe, B.; Moran, T. A.; Nambudiry, M. E. N.; Ruston, S. J. Chem. Soc., Perkin Trans. 1 1976, 2386.
34. In contrast, the use of the corresponding phosphonate gave a 4:1 E,E and Z,E mixture of dienes.
35. Mlotkowska, B.; Gross, H.; Costisella, B.; Mikolajczyk, M.; Grzejszczak, S.; Zatorski, A. J. Prakt. Chem. 1977, 319, 17.
36. Dr. J. Stelmach, in these laboratories, has recently found that a closely related intramolecular addition takes place in essentially quantitative yield at a sand bath temperature of ∼280 °C (internal temperature ∼200 °C).
37. Performed on the 3-dioxolane, mp ≈ 125 °C, of the racemic substance. We thank Kirsten Folting of the Molecular Structure Center of the Chemistry Department of Indiana University for this determination.
38. For example, see: Varasi, M.; Walker, K. A. M.; Maddox, M. L. J. Org. Chem. 1987, 52, 4235.
39. Stahl, I. Synthesis 1981, 135.
40. (a) Stork, G.; Stryker, J. M. Tetrahedron Lett. 1983, 24, 4887.
41. (b) Trost, B. M.; Flores, J.; Jebaratnam, D. J. J. Am. Chem. Soc. 1987, 109, 613.
42. 3 center.
43. This was accompanied by ∼ 16% of the product of reduction without cyclization and ∼ 19% of the product from rearrangement of the intermediate cyclized homoallylic radical, for example, see: (a) Stork, G.; Mook, R., Jr. Tetrahedron Lett. 1986, 27, 4529. (b) Beckwith, A. L. J.; O'Shea, D. M. Tetrahedron Lett. 1986, 27, 4525. The vinyl radical cyclization step to 16 was improved (65%) when it was carried out via the 2-iodobutene derivable from 15, but the overall yield was unaffected.
44. This was accompanied by ∼ 16% of the product of reduction without cyclization and ∼ 19% of the product from rearrangement of the intermediate cyclized homoallylic radical, for example, see: (a) Stork, G.; Mook, R., Jr. Tetrahedron Lett. 1986, 27, 4529. (b) Beckwith, A. L. J.; O'Shea, D. M. Tetrahedron Lett. 1986, 27, 4525. The vinyl radical cyclization step to 16 was improved (65%) when it was carried out via the 2-iodobutene derivable from 15, but the overall yield was unaffected.
45. Concerted rearragement of the epoxide should have led to the desirable β aldehyde, itself stable to the rearrangement conditions. Formation, however, of the α epimer implies that rearragement probably proceeds to the aldehyde enol in this case.
46. This proton donor (BHT) was selected in the hope that the greater steric hindrance compared to donors such as water would result in greater selectivity. This appears to be true: protonation with water gave a 1:1 mixture of the C-17 epimers.
47. Use of the trimethylsilyl ether of the 14-hydroxyl goup is desirable because separation of the 17 cyano epimers on silica is very easy.
48. Still, W. C. J. Am. Chem. Soc. 1978, 100, 1481.
49. (a) Bestmann, H. J.; Sandmeier, D. Chem. Ber. 1980, 113, 2038.
50. (b) Nickisch, K.; Klose, W.; Bohlmann, F. Chem. Ber. 1980, 113, 2038.
51. Merck Index, 11th ed.; Merck & Co: Rahway, NJ, 1989; p 3144.